相关实验视频

Updated: Jan 14, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on: January 18, 2017

弗卢瓦斯塔丁通过向CYP4Z1抑制乳腺癌的发病和进展

Huilong Li¹, Ying Chen¹, Wanjin Shi¹

¹School of Life Science and Technology, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, Jiangsu Province, China.

Communications biology

|January 12, 2026

概括

弗卢瓦斯塔丁通过向CYP4Z1.1来抑制乳腺癌的生长. 这种重新设计的药物在临床前模型中减少了瘤进展和转移,为乳腺癌提供了潜在的新疗法.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
分子生物学分子生物学

背景情况:

乳腺癌是全世界女性癌症死亡的主要原因之一.
确定乳腺癌的新型治疗点和药物是一种至关重要的未满足的需求.
药物再利用提供了一种策略,可以加速开发新的癌症疗法.

研究的目的:

使用药物重定位方法识别FDA批准的具有抗乳腺癌活性的CYP4Z1抑制剂.
评估Fluvastatin作为一种潜在的治疗药物,在乳腺癌中向CYP4Z1.
为Fluvastatin作为乳腺癌辅助疗法的疗效提供临床前证据.

主要方法:

分子对接和位点定向突变发生被用来确定Fluvastatin作为CYP4Z1抑制剂.
在体外研究中评估了Fluvastatin对乳腺癌细胞系的影响,包括干细胞,迁移,入侵和上皮-介质细胞过渡.
在体内研究中使用异种移植和转基因小鼠模型来评估Fluvastatin对瘤生长,转移和瘤发生的影响.

主要成果:

弗卢瓦斯塔丁被确定为CYP4Z1的度依赖性抑制剂,与关键活性部位残留物结合.
弗卢瓦斯塔丁治疗显著降低了乳腺癌细胞的癌症干细胞特性,迁移,入侵和上皮-介质细胞过渡.
在体内,Fluvastatin抑制了异种移植模型中的原发性瘤生长和肺转移,并延迟了相关转基因小鼠的乳腺瘤发育.

结论:

弗卢瓦斯塔丁通过抑制CYP4Z1显示出显著的抗乳腺癌活性.
这项研究验证了Fluvastatin作为一种针对CYP4Z1治疗乳腺癌的新型治疗候选药物.
临床前数据支持fluvastatin在乳腺癌联合治疗中的潜力.

更多相关视频

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

相关概念视频

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Cancer Prevention

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Inhibition of Cdk Activity

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...